Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MODV - Modivcare Reports Second Quarter 2022 Financial Results and Updates 2022 Guidance


MODV - Modivcare Reports Second Quarter 2022 Financial Results and Updates 2022 Guidance

Modivcare Inc., (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three and six months ended June 30, 2022.

Second Quarter 2022 Highlights:

  • Revenue of $628.2 million, a 32.4% increase as compared to $474.4 million in Q2 2021
  • Net income of $3.3 million or $0.24 per diluted common share
  • Adjusted EBITDA of $60.2 million, Adjusted Net Income of $28.1 million and Adjusted EPS of $1.99
  • 2022 guidance increased to account for strong second quarter and year-to-date results
  • Net cash used in operating activities during the quarter of $17.9 million
  • Cash and cash equivalents of $88.0 million as of June 30, 2022, with $1,000.0 million principal amount of debt outstanding related to the Senior Unsecured Notes due 2025 and 2029
  • Undrawn $325.0 million revolving credit facility as of June 30, 2022

“We reported solid second quarter 2022 results with Adjusted EBITDA of $60 million and revenue growth of 32 percent driven by 23 percent growth from our non-emergency medical transportation business,” said Heath Sampson, Interim Chief Executive Officer and Chief Financial Officer. “We delivered on several strategic initiatives during the quarter, including expanding our national remote patient monitoring footprint with the acquisition of Guardian Medical Monitoring and aligning more closely with our transportation providers. We also hosted our inaugural investor day where we issued 2022 guidance, which we increased this morning, and provided a long-term outlook with 2025 targets for revenue of $3 billion and Adjusted EBITDA of $300 million. I am pleased with our progress as we continue to improve outcomes and better serve patients through our unique supportive care platform that addresses the social determinants of health by broadening access to care for the nearly 34 million members we serve. I want to thank our 20,000 team members for their hard work and dedication as they are the foundation of the care and services we provide that help empower patients.”

Second Quarter 2022 Results

For the second quarter of 2022, the Company reported revenue of $628.2 million, an increase of 32.4% from $474.4 million in the second quarter of 2021.

Operating income was $23.1 million, or 3.7% of revenue, in the second quarter of 2022, compared to operating income of $27.5 million, or 5.8% of revenue, in the second quarter of 2021. Net income in the second quarter of 2022 was $3.3 million, or $0.24 per diluted common share, compared to net income of $13.7 million, or $0.96 per diluted common share, in the second quarter of 2021.

Adjusted EBITDA was $60.2 million, or 9.6% of revenue, in the second quarter of 2022, compared to $53.1 million, or 11.2% of revenue, in the second quarter of 2021.

Adjusted Net Income in the second quarter of 2022 was $28.1 million, or $1.99 per diluted common share, compared to $30.3 million, or $2.14 per diluted common share, in the second quarter of 2021.

The year-over-year increase in revenue was primarily due to incremental revenue of $42.4 million and $16.7 million associated with the acquisitions of Care Finders and VRI, respectively. NEMT revenue also increased year-over-year due to higher trip volume which drove higher revenue per member in Q2 2022.

Adjusted EBITDA increased in the second quarter of 2022 due to incremental contribution from Care Finders and VRI. This was partially offset by higher corporate general and administrative cost as the Company continued to make investments in its employees and technology.

Organizational Consolidation and Change in Segments

We operate four reportable business segments: NEMT, Personal Care, RPM, and Corporate and Other. Effective January 1, 2022, the Company completed its segment reorganization which resulted in the addition of a Corporate segment that includes the costs associated with the Company's corporate operations. The operating results of our Corporate segment include our activities related to executive, accounting, finance, internal audit, tax, legal and certain strategic and corporate development functions for each segment, as well as the results of our Matrix investment. The Company reclassified certain costs associated with this reorganization for the three and six months ended June 30, 2021 to conform to this presentation.

Updated 2022 Guidance

We are updating our 2022 guidance as follows ($ in millions):

Updated

Previous

Low

High

Low

High

Revenue

$

2,375

$

2,400

$

2,350

$

2,375

Adjusted EBITDA

$

210

$

220

$

203

$

213

Guidance excludes the effect of any future acquisitions and is based on the current operating environment.

Investor Presentation and Conference Call

Modivcare will hold a conference call to discuss its financial results on Thursday, August 4, 2022 at 8:00 a.m. ET. To access the call, please dial:

US toll-free: 1 (877) 407-8037
International: 1 (201) 689-8037

You may also access the conference call via webcast at investors.modivcare.com , where the call also will be archived.

About Modivcare

Modivcare Inc. (“Modivcare”) (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their patients. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal care and remote patient monitoring. To learn more about Modivcare, please visit www.modivcare.com .

Non-GAAP Financial Measures and Adjustments

In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), this press release includes EBITDA, Adjusted EBITDA and Adjusted EBITDA margin for the Company and its segments, Adjusted Net Income and Adjusted EPS for the Company, and Adjusted G&A expense for the Company’s segments, which are performance measures that are not recognized under GAAP. EBITDA is defined as income (loss) from continuing operations, net of taxes, before: (1) interest expense, net, (2) provision (benefit) for income taxes and (3) depreciation and amortization. Adjusted EBITDA is calculated as EBITDA before (as applicable): (1) restructuring and related charges, including severance and office closure and professional services costs, (2) certain transaction and related costs, (3) cash settled equity, (4) stock-based compensation, (5) COVID-19 related costs, net of grant income, and (6) equity in net (income) loss of investee. Adjusted EBITDA margin is calculated as Adjusted EBITDA, divided by Service revenue, net. Adjusted Net Income is calculated as income from continuing operations, net of taxes, before: (1) restructuring and related charges including severance and office closure and professional services costs, (2) certain transaction and related costs, (3) cash settled equity, (4) stock-based compensation, (5) equity in net (income) loss of investee, (6) intangible amortization expense, (7) COVID-19 related costs, net of grant income, (8) tax impacts from the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"), and (9) the income tax impact of such adjustments. Adjusted EPS is calculated as Adjusted Net Income less (as applicable): the sum of (1) dividends on convertible preferred stock plus (2) income allocated to participating securities, divided by the diluted weighted-average number of common shares outstanding as calculated for Adjusted Net Income. Adjusted G&A expense is calculated as G&A expense before (as applicable): (1) restructuring and related charges, (2) transaction costs, (3) cash settled equity, and (4) stock-based compensation. Our non-GAAP performance measures exclude expenses and amounts that are not driven by our core operating results and may be one time in nature. Excluding these expenses makes comparisons with prior periods as well as to other companies in our industry more meaningful. We believe such measures allow investors to gain a better understanding of the factors and trends affecting the ongoing operations of our business. We consider our core operations to be the ongoing activities to provide services from which we earn revenue, including direct operating costs and indirect costs to support these activities. In addition, our net income or loss in equity investee is excluded from these measures, as we do not have the ability to manage the venture, allocate resources within the venture, or directly control its operations or performance.

Our non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in our industry may calculate non-GAAP financial measures differently. In addition, there are limitations in using non-GAAP financial measures because they are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies, and exclude expenses that may have a material impact on our reported financial results. The presentation of non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the most directly comparable financial measures prepared in accordance with GAAP. We urge you to review the reconciliations of our non-GAAP financial measures to the most directly comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate our business.

Forward-Looking Statements

Certain statements contained in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as “may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend,” and similar words indicating possible future expectations, events or actions. Such forward-looking statements are based on current expectations, assumptions, estimates and projections about our business and our industry, and are not guarantees of our future performance. These statements are subject to a number of known and unknown risks, uncertainties and other factors, many of which are beyond our ability to control or predict, which may cause actual events to be materially different from those expressed or implied herein, including but not limited to: government or private insurance program funding reductions or limitations; alternative payment models or the transition of Medicaid and Medicare beneficiaries to Managed Care Organizations, or MCOs; our inability to control reimbursement rates received for our services; cost containment initiatives undertaken by private third-party payors; the effects of a public health emergency; inadequacies in, or security breaches of, our information technology systems, including the systems intended to protect our clients’ privacy and confidential information; any changes in the funding, financial viability or our relationships with our payors; pandemic infectious diseases, including the COVID-19 pandemic; disruptions to our contact center operations caused by health epidemics or pandemics like COVID-19; delays in collection, or non-collection, of our accounts receivable, particularly during any business integration; an impairment of our long-lived assets; any failure to maintain or to develop further reliable, efficient and secure information technology systems; an inability to attract and retain qualified employees; any acquisition or acquisition integration efforts; our contracts not surviving until the end of their stated terms, or not being renewed or extended; our failure to compete effectively in the marketplace; our not being awarded contracts through the government’s requests for proposals process, or our awarded contracts not being profitable; any failure to satisfy our contractual obligations or to maintain existing pledged performance and payment bonds; a failure to estimate accurately the cost of performing our contracts; any misclassification of the drivers we engage as independent contractors rather than as employees; significant interruptions in our communication and data services; not successfully executing on our strategies in the face of our competition; any inability to maintain relationships with existing patient referral sources; any failure to obtain the consent of the New York Department of Health to manage the day to day operations of our licensed in-home personal care services agency business that we acquired with our personal care segment; acquired unknown liabilities in connection with the acquisition of our personal care segment; changes in the case-mix of our personal care patients, or changes in payor mix or payment methodologies; our loss of existing favorable managed care contracts; our experiencing shortages in qualified employees and management; labor disputes or disruptions, in particular in New York; becoming subject to malpractice or other similar claims; and our reliance on others for the financial condition of our equity investment in Matrix.

The Company has provided additional information about the risks facing our business in our annual report on Form 10-K and subsequent filings most recently filed with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made and are expressly qualified in their entirety by the cautionary statements set forth herein and in our filings with the Securities and Exchange Commission, which you should read in their entirety before making an investment decision with respect to our securities. We undertake no obligation to update or revise any forward-looking statements contained in this release, whether as a result of new information, future events or otherwise, except as required by applicable law.

Modivcare Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

Three months ended June 30,

Six months ended June 30,

2022

2021

2022

2021

Service revenue, net

$

628,215

$

474,448

$

1,202,690

$

928,058

Grant income

3,330

852

3,798

3,500

Operating expenses:

Service expense

504,230

379,565

963,545

739,898

General and administrative expense

79,411

56,465

156,219

111,390

Depreciation and amortization

24,758

11,820

48,704

24,059

Total operating expenses

608,399

447,850

1,168,468

875,347

Operating income

23,146

27,450

38,020

56,211

Other expenses:

Interest expense, net

15,472

8,287

30,872

16,710

Income before income taxes and equity method investment

7,674

19,163

7,148

39,501

Provision for income taxes

2,291

5,671

1,930

10,410

Equity in net (income) loss of investee, net of tax

2,055

(180

)

1,572

(3,421

)

Net income

$

3,328

$

13,672

$

3,646

$

32,512

Earnings per common share:

Basic

$

0.24

$

0.97

$

0.26

$

2.30

Diluted

$

0.24

$

0.96

$

0.26

$

2.27

Weighted-average number of common shares outstanding:

Basic

14,047,459

14,025,325

14,035,588

14,151,946

Diluted

14,115,471

14,175,594

14,122,730

14,329,794

Modivcare Inc.

Unaudited Condensed Consolidated Balance Sheets

(in thousands)

June 30, 2022

December 31, 2021

Assets

Current assets:

Cash and cash equivalents

$

87,956

$

133,139

Accounts receivable, net

272,402

233,121

Other current assets (1)

35,426

43,574

Total current assets

395,784

409,834

Property and equipment, net

62,739

53,549

Goodwill and intangible assets, net

1,448,982

1,415,000

Equity investment

80,364

83,069

Operating lease right-of-use assets

40,326

43,750

Other long-term assets

31,368

22,223

Total assets

$

2,059,563

$

2,027,425

Liabilities and stockholders' equity

Current liabilities:

Accounts payable

$

10,622

$

8,690

Accrued contract payables

278,052

281,586

Accrued expenses and other current liabilities

123,503

123,791

Accrued transportation costs

131,282

103,294

Current portion of operating lease liabilities

9,973

9,873

Total current liabilities

553,432

527,234

Long-term debt, net of deferred financing costs

977,261

975,225

Operating lease liabilities, less current portion

32,508

34,524

Long-term contracts payables

3,686

Other long-term liabilities (2)

110,736

117,175

Total liabilities

1,677,623

1,654,158

Stockholders' equity

Stockholders' equity

381,940

373,267

Total liabilities and stockholders' equity

$

2,059,563

$

2,027,425

(1)

Includes other receivables, prepaid expenses and other current assets and short-term restricted cash.

(2)

Includes other long-term liabilities and deferred tax liabilities.

Modivcare Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

Six months ended June 30,

2022

2021

Operating activities

Net income

$

3,646

$

32,512

Depreciation and amortization

48,704

24,059

Stock-based compensation

4,496

2,659

Equity in net (income) loss of investee

2,358

(4,770

)

Deferred income taxes

(14,493

)

(2,843

)

Reduction of right-of-use asset

5,757

7,341

Other non-cash items (1)

645

(136

)

Changes in working capital (2)

93

110,969

Net cash provided by operating activities

51,206

169,791

Investing activities

Purchase of property and equipment

(15,899

)

(8,132

)

Acquisition, net of cash acquired

(78,861

)

(15,843

)

Net cash used in investing activities

(94,760

)

(23,975

)

Financing activities

Proceeds from debt

100,000

Repayment of debt

(100,000

)

Debt issuance costs

(2,415

)

Repurchase of common stock, for treasury

(39,040

)

Proceeds from common stock issued pursuant to stock option exercise

1,138

2,335

Restricted stock surrendered for employee tax payment

(607

)

(820

)

Other financing activities

(41

)

Net cash used in financing activities

(1,884

)

(37,566

)

Net change in cash, cash equivalents and restricted cash

(45,438

)

108,250

Cash, cash equivalents and restricted cash at beginning of period

133,422

183,356

Cash, cash equivalents and restricted cash at end of period

$

87,984

$

291,606

(1)

Includes provision for doubtful accounts and amortization of deferred financing costs and debt discount.

(2)

Includes accounts receivable and other receivables, prepaid expenses and other current assets, accrued contract payables, accounts payable and accrued expenses, accrued transportation costs and other long-term liabilities.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

Three months ended June 30, 2022

NEMT

Personal
Care

RPM

Corporate (3)

Total

Service revenue, net

$

448,733

$

162,737

$

16,745

$

$

628,215

Grant income

3,330

3,330

Operating expenses:

Service expense

373,724

124,445

6,061

504,230

General and administrative expense

33,588

23,346

6,742

15,735

79,411

Depreciation and amortization

7,392

12,552

4,606

208

24,758

Total operating expenses

414,704

160,343

17,409

15,943

608,399

Operating income (loss)

34,029

5,724

(664

)

(15,943

)

23,146

Other expenses:

Interest expense, net

15,472

15,472

Income (loss) before income taxes and equity method investment

34,029

5,724

(664

)

(31,415

)

7,674

Provision (benefit) for income taxes

9,563

1,601

(189

)

(8,684

)

2,291

Equity in net loss of investee, net of tax

2,055

2,055

Net Income (loss)

24,466

4,123

(475

)

(24,786

)

3,328

Interest expense, net

15,472

15,472

Provision (benefit) for income taxes

9,563

1,601

(189

)

(8,684

)

2,291

Depreciation and amortization

7,392

12,552

4,606

208

24,758

EBITDA

41,421

18,276

3,942

(17,790

)

45,849

Restructuring and related charges (1)

4,852

354

5,206

Transaction costs (2)

2,830

1,635

3,237

7,702

Cash settled equity

20

20

Stock-based compensation

173

57

2,440

2,670

COVID-19 related costs, net of grant income

34

(3,378

)

(3,344

)

Equity in net loss (income) of investee, net of tax

2,055

2,055

Adjusted EBITDA

$

46,307

$

17,901

$

5,634

$

(9,684

)

$

60,158

(1)

Restructuring and related charges include professional services costs and severance and recruiting costs.

(2)

Transaction costs include SOX integration efforts at recently acquired subsidiaries and acquisition costs.

(3)

Effective January 1, 2022, the Company completed its segment reorganization which resulted in the addition of a Corporate segment that includes the costs associated with the Company's corporate operations. Through this reorganization, it was also determined that the Matrix Investment is no longer a reportable segment, and is now reported within the Corporate segment. Prior period segment amounts have been reclassified to conform to the current presentation.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

Three months ended June 30, 2021

NEMT

Personal
Care

Corporate (3)

Total

Service revenue, net

$

364,760

$

109,688

$

$

474,448

Grant income

852

852

Operating expenses:

Service expense

292,656

86,909

379,565

General and administrative expense

28,099

14,775

13,591

56,465

Depreciation and amortization

6,936

4,884

11,820

Total operating expenses

327,691

106,568

13,591

447,850

Operating income (loss)

37,069

3,972

(13,591

)

27,450

Interest expense, net

8,287

8,287

Income (loss) before income taxes and equity method investment

37,069

3,972

(21,878

)

19,163

Provision (benefit) for income taxes

10,019

918

(5,266

)

5,671

Equity in net income of investee, net of tax

(180

)

(180

)

Net Income (loss)

27,050

3,054

(16,432

)

13,672

Interest expense, net

8,287

8,287

Provision (benefit) for income taxes

10,019

918

(5,266

)

5,671

Depreciation and amortization

6,936

4,884

11,820

EBITDA

44,005

8,856

(13,411

)

39,450

Restructuring and related charges (1)

4,044

557

4,601

Transaction costs (2)

247

1,245

1,974

3,466

Cash settled equity

4,452

4,452

Stock-based compensation

76

1,340

1,416

COVID-19 related costs, net of grant income

114

(248

)

(134

)

Equity in net income of investee, net of tax

(180

)

(180

)

Adjusted EBITDA

$

48,410

$

9,929

$

(5,268

)

$

53,071

(1)

Restructuring and related charges include professional services costs of $3.5 million and severance and office closure costs of $1.0 million.

(2)

Transaction costs include Circulation management incentive plan costs and acquisition costs related to Simplura Health Group and National MedTrans.

(3)

Effective January 1, 2022, the Company completed its segment reorganization which resulted in the addition of a Corporate segment that includes the costs associated with the Company's corporate operations. Through this reorganization, it was also determined that the Matrix Investment is no longer a reportable segment, and is now reported within the Corporate segment. Prior period segment amounts have been reclassified to conform to the current presentation, with the exception of the RPM segment, which is not included in Q2 of 2021 as it was purchased in Q3 of 2021.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

Six months ended June 30, 2022

NEMT

Personal
Care

RPM

Corporate (3)

Total

Service revenue, net

$

849,653

$

322,435

$

30,602

$

$

1,202,690

Grant income

3,798

3,798

Operating expenses:

Service expense

705,820

246,677

11,048

963,545

General and administrative expense

70,921

46,479

11,704

27,115

156,219

Depreciation and amortization

14,497

25,057

8,734

416

48,704

Total operating expenses

791,238

318,213

31,486

27,531

1,168,468

Operating income (loss)

58,415

8,020

(884

)

(27,531

)

38,020

Interest expense, net

30,872

30,872

Income (loss) before income taxes and equity method investment

58,415

8,020

(884

)

(58,403

)

7,148

Provision (benefit) for income taxes

16,138

2,241

(247

)

(16,202

)

1,930

Equity in net loss (income) of investee, net of tax

65

1,507

1,572

Net Income (loss)

42,212

5,779

(637

)

(43,708

)

3,646

Interest expense, net

30,872

30,872

Provision (benefit) for income taxes

16,138

2,241

(247

)

(16,202

)

1,930

Depreciation and amortization

14,497

25,057

8,734

416

48,704

EBITDA

72,847

33,077

7,850

(28,622

)

85,152

Restructuring and related charges (1)

10,456

181

24

385

11,046

Transaction costs (2)

4,103

2,282

5,028

11,413

Cash settled equity

7

7

Stock-based compensation

190

86

3,860

4,136

COVID-19 related costs, net of grant income

156

(3,029

)

(2,873

)

Equity in net loss (income) of investee, net of tax

65

1,507

1,572

Adjusted EBITDA

$

83,524

$

34,522

$

10,242

$

(17,835

)

$

110,453

(1)

Restructuring and related charges include professional services costs and severance and recruiting costs.

(2)

Transaction costs include SOX integration efforts at recently acquired subsidiaries and acquisition costs.

(3)

Effective January 1, 2022, the Company completed its segment reorganization which resulted in the addition of a Corporate segment that includes the costs associated with the Company's corporate operations. Through this reorganization, it was also determined that the Matrix Investment is no longer a reportable segment, and is now reported within the Corporate segment. Prior period segment amounts have been reclassified to conform to the current presentation.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

Six months ended June 30, 2021

NEMT

Personal
Care

Corporate (3)

Total

Service revenue, net

$

708,176

$

219,882

$

$

928,058

Grant income

3,500

3,500

Operating expenses:

Service expense

565,072

174,826

739,898

General and administrative expense

56,086

29,804

25,500

111,390

Depreciation and amortization

14,248

9,811

24,059

Total operating expenses

635,406

214,441

25,500

875,347

Operating income (loss)

72,770

8,941

(25,500

)

56,211

Interest expense, net

16,710

16,710

Income (loss) before income taxes and equity method investment

72,770

8,941

(42,210

)

39,501

Provision (benefit) for income taxes

19,423

2,356

(11,369

)

10,410

Equity in net income of investee, net of tax

(3,421

)

(3,421

)

Net Income (loss)

53,347

6,585

(27,420

)

32,512

Interest expense, net

16,710

16,710

Provision (benefit) for income taxes

19,423

2,356

(11,369

)

10,410

Depreciation and amortization

14,248

9,811

24,059

EBITDA

87,018

18,752

(22,079

)

83,691

Restructuring and related charges (1)

7,538

763

8,301

Transaction costs (2)

210

2,290

4,644

7,144

Cash settled equity

6,545

6,545

Stock-based compensation

76

2,489

2,565

COVID-19 related costs, net of grant income

453

(2,100

)

(1,647

)

Equity in net income of investee, net of tax

(3,421

)

(3,421

)

Adjusted EBITDA

$

95,219

$

19,018

$

(11,059

)

$

103,178

(1)

Restructuring and related charges include professional services costs of $6.4 million and severance and office closure costs of $1.7 million.

(2)

Transaction costs include Circulation management incentive plan costs and acquisition costs related to Simplura Health Group and National MedTrans.

(3)

Effective January 1, 2022, the Company completed its segment reorganization which resulted in the addition of a Corporate segment that includes the costs associated with the Company's corporate operations. Through this reorganization, it was also determined that the Matrix Investment is no longer a reportable segment, and is now reported within the Corporate segment. Prior period segment amounts have been reclassified to conform to the current presentation, with the exception of the RPM segment, which is not included in YTD 2021 as it was purchased in Q3 of 2021.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Adjusted Net Income and Adjusted Net Income per Common Share

(in thousands, except share and per share data)

Three months ended June 30,

Six months ended June 30,

2022

2021

2022

2021

Net income

$

3,328

$

13,672

$

3,646

$

32,512

Restructuring and related charges (1)

5,206

4,601

11,046

8,301

Transaction costs (2)

7,702

3,466

11,413

7,144

Cash settled equity

20

4,452

7

6,545

Stock-based compensation

2,670

1,416

4,136

2,565

Equity in net income of investee, net of tax

2,055

(180

)

1,572

(3,421

)

Intangible amortization expense

19,752

9,148

39,251

18,649

COVID-19 related costs, net of grant income

(3,344

)

(134

)

(2,873

)

(1,647

)

Tax effected impact of adjustments

(9,299

)

(6,100

)

(18,224

)

(11,417

)

Adjusted Net Income

$

28,090

$

30,341

$

49,974

$

59,231

Adjusted EPS

$

1.99

$

2.14

$

3.54

$

4.13

Diluted weighted-average number of common shares outstanding

14,115,471

14,175,594

14,122,730

14,329,794

(1)

Restructuring and related charges include severance, organizational consolidation costs and professional fees.

(2)

Transaction costs include certain transaction-related expenses and SOX integration efforts.

Modivcare Inc.

Unaudited Key Statistical and Financial Data

(in thousands, except for statistical data)

Three months ended

Six months ended

Three months
ended

June 30,
2022

June 30,
2021

%
Change

June 30,
2022

June 30,
2021

%
Change

March 31,
2022

QoQ %
Change

NEMT Segment

Service revenue, net

$

448,733

$

364,760

23.0

%

$

849,653

$

708,176

20.0

%

$

400,920

11.9

%

Purchased services expense

317,213

245,015

29.5

%

595,160

468,309

27.1

%

277,947

14.1

%

Payroll and other expense

56,511

47,641

18.6

%

110,660

96,763

14.4

%

54,149

4.4

%

Service expense

$

373,724

$

292,656

27.7

%

$

705,820

$

565,072

24.9

%

$

332,096

12.5

%

Gross profit

$

75,009

$

72,104

4.0

%

$

143,833

$

143,104

0.5

%

$

68,824

9.0

%

Gross margin

16.7

%

19.8

%

16.9

%

20.2

%

17.2

%

G&A expense

$

33,588

$

28,099

19.5

%

$

70,921

$

56,086

26.5

%

$

37,333

(10.0

)%

G&A expense adjustments:

Restructuring and related charges

4,852

4,044

20.0

%

10,456

7,538

38.7

%

5,604

(13.4

)%

Transaction costs

247

%

210

%

%

Adjusted G&A expense

$

28,736

$

23,808

20.7

%

$

60,465

$

48,338

25.1

%

$

31,729

(9.4

)%

Adjusted G&A expense % of revenue

6.4

%

6.5

%

7.1

%

6.8

%

7.9

%

Net income

$

24,466

$

27,050

(9.6

) %

$

42,212

$

53,347

(20.9

) %

$

17,746

37.9

%

Net income margin

5.5

%

7.4

%

5.0

%

7.5

%

4.4

%

Adjusted EBITDA

$

46,307

$

48,410

(4.3

)%

$

83,524

$

95,219

(12.3

)%

$

37,217

24.4

%

Adjusted EBITDA margin

10.3

%

13.3

%

9.8

%

13.4

%

9.3

%

Total paid trips (in thousands)

7,831

6,657

17.6

%

14,942

13,276

12.5

%

7,111

10.1

%

Average monthly members (in thousands)

33,792

29,756

13.6

%

32,984

30,102

9.6

%

32,176

5.0

%

Revenue per member per month

$

4.43

$

4.09

8.3

%

$

4.29

$

3.92

9.4

%

$

4.15

6.7

%

Revenue per trip

$

57.30

$

54.79

4.6

%

$

56.86

$

53.34

6.6

%

$

56.38

1.6

%

Monthly utilization

7.7

%

7.5

%

7.6

%

7.4

%

7.4

%

Purchased services per trip

$

40.51

$

36.81

10.1

%

$

39.83

$

35.27

12.9

%

$

39.09

3.6

%

Payroll and other per trip

$

7.22

$

7.16

0.8

%

$

7.41

$

7.29

1.6

%

$

7.61

(5.1

) %

Modivcare Inc.

Unaudited Key Statistical and Financial Data

(in thousands, except for statistical data)

Three months ended

Six months ended

Three months
ended

June 30,
2022

June 30,
2021

%
Change

June 30,
2022

June 30,
2021

%
Change

March 31,
2022

QoQ %
Change

Personal Care Segment

Service revenue, net

$

162,737

$

109,688

48.4

%

$

322,435

$

219,882

46.6

%

$

159,698

1.9

%

Service expense

124,445

86,909

43.2

%

246,677

174,826

41.1

%

122,232

1.8

%

Gross profit

$

38,292

$

22,779

68.1

%

$

75,758

$

45,056

68.1

%

$

37,466

2.2

%

Gross Margin

23.5

%

20.8

%

23.5

%

20.5

%

23.5

%

G&A expense

$

23,346

$

14,775

58.0

%

$

46,479

$

29,804

55.9

%

$

23,133

0.9

%

G&A expense adjustments

Restructuring and related charges

%

181

%

181

(100.0

)%

Transaction costs

2,830

1,245

127.3

%

4,103

2,290

79.2

%

1,273

122.3

%

Stock-based compensation

173

76

127.6

%

190

76

150.0

%

17

917.6

%

Adjusted G&A expense

$

20,343

$

13,454

51.2

%

$

42,005

$

27,438

53.1

%

$

21,662

(6.1

)%

Adjusted G&A expense % of revenue

12.5

%

12.3

%

13.0

%

12.5

%

13.6

%

Net income

$

4,123

$

3,054

35.0

%

$

5,779

$

6,585

(12.2

)%

$

1,656

149.0

%

Net income margin

2.5

%

2.8

%

1.8

%

3.0

%

1.0

%

Adjusted EBITDA

$

17,901

$

9,929

80.3

%

$

34,522

$

19,018

81.5

%

$

16,621

7.7

%

Adjusted EBITDA margin

11.0

%

9.1

%

10.7

%

8.6

%

10.4

%

Total hours (in thousands)

6,705

4,629

44.8

%

13,240

9,255

43.1

%

6,535

2.6

%

Revenue per hour

$

24.27

$

23.70

2.4

%

$

24.35

$

23.76

2.5

%

$

24.44

(0.7

)%

Service expense per hour

$

18.56

$

18.77

(1.1

)%

$

18.63

$

18.89

(1.4

)%

$

18.70

(0.7

)%

Modivcare Inc.

Unaudited Key Statistical and Financial Data

(in thousands, except for statistical data)

Three months ended

Six months ended

Three months
ended

June 30,
2022

June 30,
2021

%
Change

June 30,
2022

June 30,
2021

%
Change

March 31,
2022

QoQ %
Change

RPM Segment

Service revenue, net

$

16,745

N/M

$

30,602

N/M

$

13,857

20.8

%

Service expense

6,061

N/M

11,048

N/M

4,987

21.5

%

Gross profit

$

10,684

N/M

$

19,554

N/M

$

8,870

20.5

%

Gross Margin

63.8

%

63.9

%

64.0

%

G&A expense

$

6,742

N/M

$

11,704

N/M

$

4,962

35.9

%

G&A expense adjustments

Restructuring and related charges

N/M

24

N/M

24

(100.0

)%

Transaction costs

1,635

N/M

2,282

N/M

647

152.7

%

Stock-based compensation

57

N/M

86

N/M

29

96.6

%

Adjusted G&A expense

$

5,050

N/M

$

9,312

N/M

$

4,262

18.5

%

Adjusted G&A expense % of revenue

30.2

%

30.4

%

30.8

%

Net income (loss)

$

(475

)

N/M

$

(637

)

N/M

$

(162

)

193.2

%

Net income (loss) margin

(2.8

)%

(2.1

)%

(1.2

)%

Adjusted EBITDA

$

5,634

N/M

$

10,242

N/M

$

4,608

22.3

%

Adjusted EBITDA margin

33.6

%

33.5

%

33.3

%

Average monthly members (in thousands)

203

N/M

186

N/M

169

20.1

%

Revenue per member per month

$

27.50

N/M

$

27.42

N/M

$

27.33

0.6

%

Service expense per member per month

$

9.95

N/M

$

9.90

N/M

$

9.84

1.1

%

N/M - Not Meaningful. The RPM Segment was established with the acquisition of VRI on September 22, 2021 and as such, these figures are not meaningful for comparative purposes.

Modivcare Inc.

Unaudited Key Statistical and Financial Data

(in thousands)

Three months ended

Six months ended

Three months
ended

June 30,
2022

June 30,
2021

%
Change

June 30,
2022

June 30,
2021

%
Change

March 31,
2022

QoQ %
Change

Corporate and Other Segment

G&A expense

$

15,735

$

13,591

15.8

%

$

27,115

$

25,500

6.3

%

$

11,380

38.3

%

G&A expense adjustments

Restructuring and related charges

354

557

(36.4

)%

385

763

(49.5

)%

31

1041.9

%

Transaction costs

3,237

1,974

64.0

%

5,028

4,644

8.3

%

1,791

80.7

%

Cash settled equity

20

4,452

(99.6

)%

7

6,545

(99.9

)%

(13

)

(253.8

)%

Stock-based compensation

2,440

1,340

82.1

%

3,860

2,489

55.1

%

1,420

71.8

%

Adjusted G&A expense

$

9,684

$

5,268

83.8

%

$

17,835

$

11,059

61.3

%

$

8,151

18.8

%

Adjusted G&A expense % of consolidated revenue

1.5

%

1.1

%

1.5

%

1.2

%

1.4

%

Three months ended

Six months ended

Three months
ended

June 30,
2022

June 30,
2021

%
Change

June 30,
2022

June 30,
2021

%
Change

March 31,
2022

QoQ %
Change

Consolidated Modivcare

G&A expense

$

79,411

$

56,465

40.6

%

$

156,219

$

111,390

40.2

%

$

76,808

3.4

%

G&A expense adjustments

Restructuring and related charges

5,206

4,601

13.1

%

11,046

8,301

33.1

%

5,840

(10.9

)%

Transaction costs

7,702

3,466

122.2

%

11,413

7,144

59.8

%

3,711

107.5

%

Cash settled equity

20

4,452

(99.6

)%

7

6,545

(99.9

)%

(13

)

(253.8

)%

Stock-based compensation

2,670

1,416

88.6

%

4,136

2,565

61.2

%

1,466

82.1

%

Adjusted G&A expense

$

63,813

$

42,530

50.0

%

$

129,617

$

86,835

49.3

%

$

65,804

(3.0

)%

Adjusted G&A expense % of revenue

10.2

%

9.0

%

10.8

%

9.4

%

11.5

%

View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005265/en/

Investor Relations Contact
Kevin Ellich,
Head of Investor Relations
(303) 728-7012
Kevin.Ellich@modivcare.com

Stock Information

Company Name: ModivCare Inc Com
Stock Symbol: MODV
Market: NASDAQ
Website: modivcare.com

Menu

MODV MODV Quote MODV Short MODV News MODV Articles MODV Message Board
Get MODV Alerts

News, Short Squeeze, Breakout and More Instantly...